UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark One)
x QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the quarterly period ended July 1, 2006
or
o TRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period
from
to .
Commission
File Number: 000-10030
APPLE COMPUTER, INC.
(Exact name of registrant
as specified in its charter)
CALIFORNIA
942404110
(State
or other jurisdiction
(I.R.S.
Employer Identification No.)
of
incorporation or organization)
1 Infinite Loop
Cupertino, California
95014
(Address
of principal executive offices)
(Zip
Code)
Registrant s telephone
number, including area code: (408) 996-1010
Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes x No o
Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated filer, or a
non-accelerated filer. See definition of
accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange
Act.
Large
accelerated filer x
Accelerated
filer o
Non-accelerated
filer o
Indicate by check mark whether the
registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No x
859,273,757 shares of
common stock issued and outstanding as of December 13, 2006
Explanatory
Note
In this Form 10-Q,
Apple Computer, Inc. ( Apple or the Company ) is restating its condensed
consolidated balance sheet as of September 24, 2005, the related consolidated
statements of operations for the three and nine months ended June 25, 2005, and
the related consolidated statement of cash flows for the nine months ended June
25, 2005. In the Company s Form 10-K for
the year ended September 30, 2006 to be filed with the Securities and Exchange
Commission (the 2006 Form 10-K ), the Company is restating its consolidated
balance sheet as of September 24, 2005, and the related consolidated statements
of operations, shareholders equity, and cash flows for each of the fiscal
years ended September 24, 2005 and September 25, 2004, and each of the quarters
in fiscal year 2005.
The Company s 2006
Form 10-K also reflects the restatement of Selected Consolidated Financial
Data in Item 6 for the fiscal years ended September 2005, 2004, 2003, and
2002, and Management s Discussion and Analysis of Financial Condition and
Results of Operations in Item 7 for the fiscal years ended September 24, 2005
and September 25, 2004.
Previously filed
annual reports on Form 10-K and quarterly reports on Form 10-Q affected by the
restatements have not been amended and should not be relied on.
On
June 29, 2006, the Company announced that an internal review had discovered
irregularities related to the issuance of certain stock option grants made
between 1997 and 2001, including a grant to its Chief Executive Officer ( CEO )
Steve Jobs. The Company also announced
that a Special Committee of outside directors ( Special Committee ) had been
formed and had hired independent counsel to conduct a full investigation of the
Company s past stock option granting practices. On October 4, 2006, the
Company announced the key results of the Special Committee s investigation,
which are set forth in the Company s Form 8-K filed on that date.
As
a result of the internal review and the independent investigation, management
has concluded, and the Audit and Finance Committee of the Board of Directors
agrees, that incorrect measurement dates were used for financial accounting
purposes for certain stock option grants made in prior periods. Therefore, the Company has recorded
additional non-cash stock-based compensation expense and related tax effects
with regard to past stock option grants, and the Company is restating previously
filed financial statements in this Form 10-Q and the 2006 Form 10-K. These adjustments, after tax, amounted to $4
million, $7 million, and $10 million in fiscal years 2006, 2005 and 2004,
respectively. The adjustment to 2006 was
recorded in the fourth quarter of fiscal year 2006 due to its insignificance.
The
independent counsel and its forensic accountants ( Investigative Team )
reviewed the facts and circumstances surrounding stock option grants made on
259 dates. The Investigative Team spent over 26,500 person-hours searching more
than one million physical and electronic documents and interviewing more than
40 current and former directors, officers, employees, and advisors. Based on a review of the totality of evidence
and the applicable law, the Special Committee found no misconduct by current
management. The Special Committee s investigation identified a number of grants
for which grant dates were intentionally selected in order to obtain favorable
exercise prices. The terms of these and
certain other grants, as discussed below, were finalized after the originally
assigned grant dates. The Special
Committee concluded that the procedures for granting, accounting for, and
reporting stock option grants did not include sufficient safeguards to prevent
manipulation. Although the investigation found that CEO Steve Jobs was aware or
recommended the selection of some favorable grant dates, he did not receive or
financially benefit from these grants or appreciate the accounting
implications. The Special Committee also found that the investigation had
raised serious concerns regarding the actions of two former officers in
connection with the accounting, recording and reporting of stock option grants.
Based
on the evidence and findings from the Company s internal review and the Special
Committee s independent investigation, an analysis was performed of the measurement
dates for the 42,077 stock option grants made on 259 dates between October 1996
and January 2003 (the relevant period ). The Company believes that the
analysis was properly limited to the relevant period. In addition to analyzing
all grants made during the relevant period, the Company sampled certain grants
between 1994 and 1997 and found none that required accounting adjustments. The
first grants for which stock-based compensation expense is required are dated
December 29, 1997. The Company also examined grants made after the relevant
period and found none that required accounting adjustments.
Moreover,
in the years after 2002, Apple made significant changes in its stock option
granting practices in response to evolving legal, regulatory and accounting
requirements.
Consistent
with the accounting literature and recent guidance from the Securities and
Exchange Commission ( SEC ), the grants during the relevant period were
organized into categories based on grant type and process by which the grant
was finalized. The Company analyzed the evidence related to each category of
grants including, but not limited to, electronic and physical documents,
document metadata, and witness interviews.
Based on the relevant facts and circumstances, the Company applied the
controlling accounting standards to determine, for every grant within each
category, the proper measurement date.
If the measurement date is not the originally assigned grant date,
accounting adjustments were made as required, resulting in stock-based
compensation expense and related tax effects.
The 42,077 grants were classified as follows: (1) 17 grants to persons
elected or appointed to the Board of Directors ( director grants ); (2) 3,892 grants
to employees under the Monday/Tuesday Plan described below ( Monday/Tuesday
grants ); (3) 27,096 grants made in broad-based awards to large numbers of
employees, usually on an annual basis ( focal grants ); (4) 9,988 other grants
ratified at meetings of the Board or Compensation Committee ( meeting grants );
(5) 1,082 other grants ratified by unanimous written consent ( UWC ) of the
Board or Compensation Committee ( other UWC grants ); and (6) two grants to the
CEO ( CEO grants ). All references to
the number of option shares, option exercise prices and share prices in this
Explanatory Note have not been adjusted for any subsequent stock splits.
With the exception of director grants, all stock option grants were
subject to ratification by the Board or Compensation Committee at a meeting or
by UWC. Following approval of the grants
at a meeting or by UWC, the Company s legal staff would prepare a Secretary s
Certificate certifying the ratification of the grants. Based on the facts and circumstances
described below, the Company has concluded that the recipients and terms of
certain grants were fixed for accounting purposes before ratification pursuant
to parameters previously approved by the Board or Compensation Committee
through the Monday/Tuesday Plan and the focal process. As further discussed below, within these
parameters, management had the authority to determine the recipients and terms
for each grant. Thus, the Company has
concluded that the measurement dates for these grants occurred when
management s process for allocating these grants was completed and the grants
were ready for ratification, which was considered perfunctory. With regard to all other grants, the Company
has concluded that the grants were finalized and the measurement dates occurred
when the grants were ratified. For many
grants, however, the dates of ratification cannot be established because the
dates the UWCs were executed by the Board or Compensation Committee members or
received by the Company are not available.
For such grants, the Company has concluded that the date of the
preparation of the Secretary s Certificate is the best alternative for
determining the actual date of ratification.
As discussed below, the Company s analysis determined that the originally
assigned grant dates for 6,428 grants on 42 dates are not the proper
measurement dates. Accordingly, after
accounting for forfeitures, the Company has recognized stock-based compensation
expense of $105 million on a pre-tax basis over the respective awards vesting
terms. No adjustments were required for the remaining 35,649 grants. The adjustments were determined by category
as follows:
Director Grants Seventeen director grants were made during the
relevant period. Two director grants
were made pursuant to a 1997 plan that dated the grants on the enactment of the
plan. The remaining fifteen grants were
automatically made under the Director Stock Option Plan for non-employee
directors, which was approved by shareholders in 1998, on the date of a
director s election or appointment to the Board and on subsequent
anniversaries, beginning on the fourth anniversary. Accordingly, the analysis determined that the
originally assigned grant date for each director grant is the measurement date,
and no accounting adjustments are required.
Monday/Tuesday Grants Beginning in December 1998, 3,892 new hire
grants and grants for promotion and retention purposes ( promotion/retention
grants ) were made during the relevant period under the Monday/Tuesday
Plan. Under the Monday/Tuesday Plan,
new hire grants made within pre-established guidelines approved by the Board or
Compensation Committee were dated on the Monday that the recipient started work
(or the following Monday, if the recipient started on another day). The
Company s analysis showed this process to be reliable with very low error
rates. Promotion/retention grants, also
based on pre-established guidelines, were made generally on the first Tuesday
of each month. The Company has concluded that the new hire and
promotion/retention grants made
pursuant to the Monday/Tuesday Plan within pre-established guidelines
do not require adjustment, with the exception of six grants that were
erroneously dated before the employees start dates. For 120 new hire and
promotion/retention grants made outside the guidelines, however, the Company
has concluded that the measurement dates are the dates of ratification by the
Board or Compensation Committee rather than the dates used for grants within
guidelines. Accordingly, based on the
methodology described above, the Company has recognized stock-based
compensation expense of $6 million from 126 grants. If other dates in the period between the
preparation of the UWC and the preparation of the Secretary s Certificate had
been used as measurement dates for grants whose actual ratification dates are
unknown, the total stock-based compensation expense would have ranged from
approximately $3 million to $7 million.
Focal Grants During the relevant period, 27,096 focal grants were
made to employees typically on an annual basis as part of an extensive process
that required several months to complete. Pursuant to limits, guidelines and
practices previously approved by the Board or Compensation Committee, managers
throughout the Company would make recommendations for grants to employees in
their areas of responsibility. After
senior management had determined that the grants were made in accordance with
these established limits, guidelines and practices, management treated the
grants as final when they were submitted to the Board or Compensation Committee
for ratification. The Company has
concluded that for 5,595 grants on five dates, the originally assigned grant
dates are not the proper measurement dates.
For these grants, management s process for finalizing the grants was
completed after the originally assigned grant dates. As a result, the Company has recognized $29
million of stock-based compensation expense.
For two of the five grant dates comprising 3,744 grants, the evidence
shows that the grants were finalized and the measurement date occurred one day
after the originally assigned grant dates.
The grants on these two dates represent more than $16 million of the
total $29 million of stock-based compensation expense resulting from focal
grants.
Other Meeting Grants During the relevant period, meetings of the
Board or Compensation Committee were held to ratify 9,988 grants that are not
Monday/Tuesday, focal or CEO grants. The grant dates and measurement dates for
these grants are the meeting dates when the grants were ratified, with the
exception of 46 grants. Forty-two of
these 46 grants are dated concurrent with a meeting that considered and
approved certain grants, but the evidence indicates that all of the grants may
not have been finalized until a later date. One of the 46 grants was approved and dated at
another meeting, but the recipient, who was becoming employed by the Company as
part of a corporate acquisition, did not start until a later date. Two other
grants were approved before the employees start dates. Another grant was mistakenly cancelled and
subsequently reinstated, requiring an accounting adjustment. Thus, for these 46
grants the Company has concluded that the originally assigned grant dates are
not the proper measurement dates. As a
result, the Company has recognized $2 million of stock-based compensation
expense.
Other UWC Grants During the relevant period, 1,082 grants were
approved by UWCs for a variety of purposes, including executive recruitment,
retention, promotion and new hires outside the Monday/Tuesday process. These
grants were not made pursuant to pre-established guidelines adopted by the
Board or Compensation Committee. Therefore, the Company has concluded that
these grants were not finalized for accounting purposes until ratification by
the Board or Compensation Committee. Accordingly, for 660 grants, the Company
has concluded that the originally assigned grant dates are not the proper
measurement dates. As a result, the Company has recognized $48 million of
stock-based compensation expense. If other dates in the period from the
preparation of the UWC to the preparation of the Secretary s Certificate had
been used as measurement dates for grants whose actual ratification dates are
unknown, the total stock-based compensation would have ranged from
approximately $35 million to $56 million.
CEO Grants During the relevant period, the Company made two grants to
CEO Steve Jobs. The first grant, dated
January 12, 2000, was for 10 million option shares. The second grant, dated October 19, 2001, was
for 7.5 million option shares. Both grants were cancelled in March 2003 prior
to being exercised, when Mr. Jobs received 5 million shares of restricted
stock.
With respect to the grant dated January 12, 2000, the Board on December
2, 1999, authorized a special CEO Compensation Committee to grant Mr. Jobs up
to 15 million shares. The evidence
indicates that the CEO Compensation Committee finalized the terms of the grant
on January 12, 2000, although the Committee s action was memorialized in a UWC transmitted
on January 18, 2000. Because the measurement date is the originally assigned
grant date, the Company has not recognized any stock-based compensation expense
from this grant. If the Company had determined
that the measurement date was the date when the UWC was executed or
received, then additional stock-based compensation would have been recognized.
The grant dated October 19, 2001 was originally approved at a Board
meeting on August 29, 2001, with an exercise price of $17.83. The terms of the grant, however, were not
finalized until December 18, 2001. The
grant was dated October 19, 2001, with an exercise price of $18.30. The approval for the grant was improperly
recorded as occurring at a special Board meeting on October 19, 2001. Such a special Board meeting did not
occur. There was no evidence, however,
that any current member of management was aware of this irregularity. The Company has recognized $20 million in
stock-based compensation expense for this grant, reflecting the difference
between the exercise price of $18.30 and the share price on December 18, 2001
of $21.01.
The incremental impact from recognizing stock-based compensation
expense resulting from the investigation of past stock option grants is as
follows (dollars in millions):
Fiscal Year
Pre-Tax Expense (Income)
After Tax Expense
1998
(1
1999
2000
13
2001
19
13
2002
29
23
2003
16
12
2004
13
10
2005
2006
Total
105
84
Additionally, the Company has restated the pro forma
expense under Statement of Financial Accounting Standards ( SFAS ) No. 123 in
Note 1 of the Notes to Condensed Consolidated Financial Statements of this Form
10-Q and in Note 1 of the Notes to Consolidated Financial Statements of the
2006 Form 10-K to reflect the impact of these adjustments.
PART I.
FINANCIAL INFORMATION
Item 1.
Financial Statements
APPLE COMPUTER, INC.
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(in millions, except share and per share amounts)
Three Months Ended
Nine Months Ended
July 1,
2006
June 25,
2005
July 1,
2006
June 25,
2005
As Restated (1)
As Restated (1)
Net sales
4,370
3,520
14,478
10,253
Cost of sales
(2)
3,045
2,476
10,292
7,246
Gross margin
1,325
1,044
4,186
3,007
Operating
expenses:
Research and development (2)
175
145
533
388
Selling, general, and administrative (2)
584
473
1,808
1,393
Total operating expenses
759
618
2,341
1,781
Operating income
566
426
1,845
1,226
Other income and
expense
95
46
252
105
Income before
provision for income taxes
661
472
2,097
1,331
Provision for
income taxes
189
153
650
431
Net income
472
319
1,447
900
Earnings per
common share:
Basic
0.55
0.39
1.72
1.12
Diluted
0.54
0.37
1.65
1.05
Shares used in
computing earnings per share (in thousands):
Basic
851,375
815,092
840,759
804,098
Diluted
876,368
860,803
876,971
853,238
(1) See Note 2,
Restatement of Condensed Consolidated Financial Statements, in Notes to
Condensed Consolidated Financial Statements.
(2) Includes stock-based
compensation expense, which was allocated as follows:
Cost of sales
16
Research and development
12
40
Selling,
general, and administrative
19
10
67
30
See accompanying Notes to Condensed Consolidated
Financial Statements.
APPLE COMPUTER, INC.
CONDENSED
CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except share amounts)
July 1, 2006
September 24, 2005
As Restated (1)
ASSETS:
Current assets:
Cash and cash equivalents
8,013
3,491
Short-term investments
1,163
4,770
Accounts receivable, less allowances of $51 and $46,
respectively
1,089
895
Inventories
213
165
Deferred tax assets
491
331
Other current assets
1,522
648
Total current assets
12,491
10,300
Property, plant,
and equipment, net
1,197
817
Goodwill
38
69
Acquired
intangible assets, net
37
27
Other assets
1,351
303
Total assets
15,114
11,516
LIABILITIES AND SHAREHOLDERS EQUITY:
Current
liabilities:
Accounts payable
2,513
1,779
Accrued expenses
2,510
1,708
Total current liabilities
5,023
3,487
Non-current
liabilities
761
601
Total liabilities
5,784
4,088
Commitments and
contingencies
Shareholders
equity:
Common stock, no par value; 1,800,000,000 shares
authorized;
852,987,629 and 835,019,364 shares issued and outstanding, respectively
4,249
3,564
Deferred stock compensation
(61
Retained earnings
5,065
3,925
Accumulated other comprehensive income
16
Total shareholders equity
9,330
7,428
Total
liabilities and shareholders equity
15,114
11,516
(1) See Note 2,
Restatement of Condensed Consolidated Financial Statements, in Notes to
Condensed Consolidated Financial Statements.
See accompanying Notes to
Condensed Consolidated Financial Statements.
APPLE COMPUTER, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)
Nine Months Ended
July 1, 2006
June 25, 2005
As Restated (1)
Cash and cash
equivalents, beginning of the period
3,491
2,969
Operating
Activities:
Net income
1,447
900
Adjustments to reconcile net income to cash
generated by operating activities:
Depreciation, amortization, and accretion
159
128
Stock-based compensation expense
123
37
Provision for deferred income taxes
201
Excess tax benefits from stock options
279
Gain on sale of PowerSchool net assets
(4
Loss on disposition of property, plant, and
equipment
Changes in
operating assets and liabilities:
Accounts receivable
(194
(53
Inventories
(48
(92
Other current assets
(880
(11
Other assets
(1,113
(17
Accounts payable
734
79
Other liabilities
735
527
Cash generated by operating activities
1,165
1,783
Investing
Activities:
Purchases of short-term investments
(4,393
(7,624
Proceeds from maturities of short-term
investments
7,827
5,108
Proceeds from sales of short-term investments
175
582
Purchases of long-term investments
(12
Proceeds from sale of PowerSchool net assets
40
Purchases of property, plant, and equipment
(512
(164
Other
(39
(29
Cash generated by (used for) investing activities
3,086
(2,127
Financing
Activities:
Proceeds from issuance of common stock
286
469
Excess tax benefits from stock-based compensation
339
Repurchases of common stock
(354
Cash generated by financing activities
271
469
Increase in cash
and cash equivalents
4,522
125
Cash and cash
equivalents, end of the period
8,013
3,094
Supplemental
cash flow disclosure:
Cash paid for income taxes, net
108
108
(1) See Note 2,
Restatement of Condensed Consolidated Financial Statements, in Notes to
Condensed Consolidated Financial Statements.
See accompanying Notes to Condensed Consolidated
Financial Statements.
APPLE COMPUTER, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 1 - Summary of Significant
Accounting Policies
Apple Computer, Inc. and
its wholly-owned subsidiaries ( Apple or the Company ) designs, manufactures,
and markets personal computers and related software, services, peripherals, and
networking solutions. The Company also
designs, develops, and markets a line of portable digital music players along
with related accessories and services including the online sale of third-party
audio and video products. The Company
sells its products worldwide through its online stores, its retail stores, its
direct sales force, and third-party wholesalers, resellers, and value-added
resellers. In addition, the Company
sells a variety of third-party Macintosh and iPod compatible products including
application software, printers, storage devices, speakers, headphones, and
various other accessories and supplies through its online and retail
stores. The Company sells to education,
consumer, creative professional, business, and government customers.
Basis of
Presentation and Preparation
The accompanying
condensed consolidated financial statements include the accounts of the
Company. Intercompany accounts and
transactions have been eliminated. The preparation of these condensed
consolidated financial statements in conformity with U.S. generally accepted
accounting principles requires management to make estimates and assumptions
that affect the amounts reported in these condensed consolidated financial
statements and accompanying notes. Actual results could differ materially from
those estimates. Certain prior year amounts in the consolidated financial
statements and notes thereto have been reclassified to conform to the current
year presentation.
These condensed
consolidated financial statements and accompanying notes should be read in
conjunction with the Company s annual consolidated financial statements and the
notes thereto for the fiscal year ended September 30, 2006, included in the
2006 Annual Report on Form 10-K to be filed with the Securities and Exchange
Commission (the 2006 Form 10-K ).
Typically, the Company s
fiscal year ends on the last Saturday of September. Fiscal year 2005 was a
52-week year. However, approximately every six years, the Company reports a
53-week fiscal year to align its fiscal quarters with calendar quarters by
adding a week to its first fiscal quarter. The Company added this additional
week in the first fiscal quarter of its fiscal year 2006. Unless otherwise stated, references to
particular years or quarters refer to the Company s fiscal years ended in
September and the associated quarters of those fiscal years.
Software Development Costs
Research and
development costs are generally expensed as incurred. Development costs of computer software to be
sold, leased, or otherwise marketed are subject to capitalization beginning
when a product s technological feasibility has been established and ending when
a product is available for general release to customers pursuant to Statement
of Financial Accounting Standards ( SFAS ) No. 86, Computer
Software to be Sold, Leased, or Otherwise Marketed. In most
instances, the Company s products are released soon after technological
feasibility has been established. Therefore, costs incurred subsequent to
achievement of technological feasibility are usually not significant, and
generally all software development costs have been expensed as incurred.
In 2004, the Company
began incurring substantial development costs associated with Mac OS X version
10.4 Tiger ( Tiger ) subsequent to achievement of technological feasibility as
evidenced by public demonstration in August 2004 and the subsequent release of
a developer beta version of the product. During the first nine months of 2005, the
Company capitalized $29.7 million of costs associated with the development of
Tiger. In accordance with SFAS No. 86,
amortization of this asset to cost of sales began in April 2005 when the
Company started shipping Tiger and is being recognized on a straight-line basis
over a three-year estimated useful life.
Stock-Based Compensation
On September 25,
2005, the Company adopted SFAS No. 123 (revised 2004) ( SFAS No. 123R ), Share-Based Payment, which addresses the accounting for
stock-based payment transactions in which an enterprise receives employee
services in exchange for (a) equity instruments of the enterprise or (b)
liabilities that are based on the fair
value of the
enterprise s equity instruments or that may be settled by the issuance of such
equity instruments. In January 2005, the Securities and Exchange
Commission ( SEC ) issued Staff Accounting Bulletin ( SAB ) No. 107,
which provides supplemental implementation guidance for SFAS No. 123R.
SFAS No. 123R eliminates the ability to account for stock-based compensation
transactions using the intrinsic value method under Accounting Principles Board
( APB ) Opinion No. 25, Accounting for Stock
Issued to Employees, and instead generally requires that such
transactions be accounted for using a fair-value-based method. The Company uses the Black-Scholes-Merton